ABVC BioPharma (ABVC) vs BeyondSpring (BYSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BeyondSpring (BYSI) has outperformed ABVC BioPharma (ABVC) over the past year, losing 64.1% versus a loss of 68.9%. Over five years, BYSI leads with a -96.1% price change compared with -96.3% for ABVC. ABVC BioPharma is the larger company by market cap ($26.2 million vs $25.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABVC | BYSI |
|---|---|---|
| Share price | $0.98 | $0.609 |
| Market cap | $26.16M | $25.04M |
| 1-day change | -2.00% | -5.51% |
| YTD return | -53.05% | -60.46% |
| 1-year return | -68.94% | -64.09% |
| 5-year return | -96.31% | -96.11% |
| EPS (TTM) | $-0.30 | $-0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.33 | $2.44 |
| 52-week low | $0.707 | $0.566 |
| Distance from 52-week high | -70.57% | -75.04% |
| Average volume | 118.80K | 855.49K |
| Shares outstanding | 26.69M | 41.12M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ABVC vs BYSI FAQ
Which is bigger, ABVC BioPharma or BeyondSpring?
ABVC BioPharma (ABVC) is larger, with a market capitalization of $26.16M compared with $25.04M for BeyondSpring (BYSI).
Which stock has performed better over the past year, ABVC or BYSI?
BYSI returned -64.09% over the past 12 months, compared with -68.94% for ABVC (price return, excluding dividends). Past performance does not predict future results.
Are ABVC BioPharma and BeyondSpring in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.